Cadrenal Therapeutics (CVKD) Q1 2025 Earnings

13MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-2.25
-1.53
-0.8
-0.08

Details

Expected EPS
-1.72
Actual EPS
-2.03
Surprise EPS
-0.31
Surprise Percent
+18.02%

Description

Cadrenal Therapeutics (CVKD) has reported earnings of -2.03 per share for Q1 2025.

0 Comments

Share your thoughts